HK1214511A1 - 鹽酸蘭地洛爾在快速性心律失常的長期治療中的用途 - Google Patents

鹽酸蘭地洛爾在快速性心律失常的長期治療中的用途

Info

Publication number
HK1214511A1
HK1214511A1 HK16102471.6A HK16102471A HK1214511A1 HK 1214511 A1 HK1214511 A1 HK 1214511A1 HK 16102471 A HK16102471 A HK 16102471A HK 1214511 A1 HK1214511 A1 HK 1214511A1
Authority
HK
Hong Kong
Prior art keywords
tachyarrhythmias
long
term treatment
landiolol hydrochloride
landiolol
Prior art date
Application number
HK16102471.6A
Other languages
English (en)
Inventor
Gnther Krumpl
Original Assignee
Aop Orphan Pharmaceuticals Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48226997&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1214511(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aop Orphan Pharmaceuticals Ag filed Critical Aop Orphan Pharmaceuticals Ag
Publication of HK1214511A1 publication Critical patent/HK1214511A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
HK16102471.6A 2013-04-26 2016-03-03 鹽酸蘭地洛爾在快速性心律失常的長期治療中的用途 HK1214511A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13165582.1A EP2796139A1 (en) 2013-04-26 2013-04-26 Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias
PCT/EP2014/058456 WO2014174076A1 (en) 2013-04-26 2014-04-25 Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias

Publications (1)

Publication Number Publication Date
HK1214511A1 true HK1214511A1 (zh) 2016-07-29

Family

ID=48226997

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16102471.6A HK1214511A1 (zh) 2013-04-26 2016-03-03 鹽酸蘭地洛爾在快速性心律失常的長期治療中的用途

Country Status (28)

Country Link
US (1) US10722516B2 (zh)
EP (2) EP2796139A1 (zh)
JP (1) JP2016517860A (zh)
KR (1) KR102268161B1 (zh)
CN (1) CN105324118A (zh)
AU (1) AU2014259352B2 (zh)
BR (1) BR112015027051A2 (zh)
CA (1) CA2910066C (zh)
CL (1) CL2015003145A1 (zh)
DK (1) DK2988750T3 (zh)
EA (1) EA030589B1 (zh)
ES (1) ES2906551T3 (zh)
HK (1) HK1214511A1 (zh)
HR (1) HRP20220470T1 (zh)
HU (1) HUE058189T2 (zh)
IL (1) IL242220B (zh)
LT (1) LT2988750T (zh)
MX (1) MX2015014939A (zh)
NZ (1) NZ713295A (zh)
PH (1) PH12015502465A1 (zh)
PL (1) PL2988750T3 (zh)
PT (1) PT2988750T (zh)
SG (1) SG11201508824RA (zh)
SI (1) SI2988750T1 (zh)
TN (1) TN2015000480A1 (zh)
UA (1) UA117243C2 (zh)
WO (1) WO2014174076A1 (zh)
ZA (1) ZA201508050B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2796139A1 (en) 2013-04-26 2014-10-29 AOP Orphan Pharmaceuticals AG Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias
CN114031601B (zh) * 2022-01-12 2022-03-18 南京桦冠生物技术有限公司 一种盐酸兰地洛尔的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004323370A (ja) 2003-04-22 2004-11-18 Ono Pharmaceut Co Ltd 麻酔薬と塩酸ランジオロールとを組み合わせてなる併用剤
US20060286037A1 (en) 2003-08-08 2006-12-21 Ono Pharmaceutical Co., Ltd. Heart-slowing drug containing short-acting ß blocker as the active ingredient
JP4784037B2 (ja) 2003-08-27 2011-09-28 独立行政法人国立がん研究センター 塩酸ランジオロールを含有する頻脈性不整脈の治療剤
CN1827109A (zh) 2006-04-14 2006-09-06 北京润德康医药技术有限公司 一种以兰洛地尔及其盐为活性成分的冻干粉针制剂及其制备工艺
EP2234614B1 (de) * 2007-12-21 2012-10-17 AOP Orphan Pharmaceuticals AG Pharmazeutische zusammensetzung zur parenteralen verabreichung eines ultrakurzwirksamen beta-adrenorezeptor antagonisten
CN101732319B (zh) 2008-11-26 2012-11-07 天津市汉康医药生物技术有限公司 含有盐酸兰地洛尔活性成分的注射用药物组合物及其制备方法
CN102232930B (zh) 2010-05-06 2013-03-27 南京海辰药业有限公司 盐酸兰地洛尔药物组合物及其制备方法
JP2010248263A (ja) 2010-08-04 2010-11-04 National Cancer Center 塩酸ランジオロールを含有する頻脈性不整脈の治療剤
CN102475706A (zh) 2010-11-28 2012-05-30 天津市汉康医药生物技术有限公司 一种供注射用盐酸兰地洛尔药物组合物及其制备方法
EP2796139A1 (en) 2013-04-26 2014-10-29 AOP Orphan Pharmaceuticals AG Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias

Also Published As

Publication number Publication date
LT2988750T (lt) 2022-05-10
ES2906551T3 (es) 2022-04-19
DK2988750T3 (da) 2022-04-04
HRP20220470T1 (hr) 2022-05-27
CN105324118A (zh) 2016-02-10
IL242220A0 (en) 2015-11-30
PH12015502465A1 (en) 2016-02-22
CL2015003145A1 (es) 2016-06-24
US20160074411A1 (en) 2016-03-17
EA201592058A1 (ru) 2016-03-31
SG11201508824RA (en) 2015-11-27
EP2796139A1 (en) 2014-10-29
IL242220B (en) 2020-07-30
CA2910066C (en) 2021-10-19
EP2988750A1 (en) 2016-03-02
US10722516B2 (en) 2020-07-28
EA030589B1 (ru) 2018-08-31
MX2015014939A (es) 2016-01-12
PL2988750T3 (pl) 2022-05-16
AU2014259352B2 (en) 2017-03-02
HUE058189T2 (hu) 2022-07-28
CA2910066A1 (en) 2014-10-30
JP2016517860A (ja) 2016-06-20
ZA201508050B (en) 2017-11-29
AU2014259352A1 (en) 2015-11-05
KR20160020411A (ko) 2016-02-23
KR102268161B1 (ko) 2021-06-23
NZ713295A (en) 2020-08-28
WO2014174076A1 (en) 2014-10-30
TN2015000480A1 (en) 2017-04-06
UA117243C2 (uk) 2018-07-10
PT2988750T (pt) 2022-03-01
SI2988750T1 (sl) 2022-05-31
EP2988750B1 (en) 2022-01-19
BR112015027051A2 (pt) 2020-03-10

Similar Documents

Publication Publication Date Title
HK1216251A1 (zh) 吡唑並吡咯烷衍生物及其治病作用
ZA201504902B (en) Bcl-2bcl-xl inhibitors and therapeutic methods using the same
GB201320729D0 (en) Therapeutic compounds and their use
PL3004112T3 (pl) Pochodne pirazolo-pirolidyn-4-onu oraz ich zastosowanie w leczeniu choroby
ZA201607581B (en) Dosage forms and therapeutic uses l-4lchlorokynurenine
GB201311361D0 (en) Compounds and their therapeutic use
GB201308736D0 (en) Compounds and their therapeutic use
HK1214511A1 (zh) 鹽酸蘭地洛爾在快速性心律失常的長期治療中的用途
GB201308753D0 (en) Compounds and their use in therapy
HK1209033A1 (zh) 奧地帕西在治療黏多醣症病中的應用
GB201308217D0 (en) Compounds and their use in therapy
GB201317804D0 (en) Therapeutic compounds and their use
GB201316173D0 (en) Compounds and their therapeutic use
GB201312131D0 (en) Drug combination and its use in therapy
GB201312129D0 (en) Drug combination and its use in therapy
GB201312128D0 (en) Drug combination and its use in therapy
GB201307677D0 (en) Compounds and their therapeutic use
AP2015008849A0 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of disease